BioMed Research International

Nephrotic Syndrome: Genetics, Mechanism, and Therapies


Status
Published

Lead Editor

1Yonsei University College of Medicine, Seoul, Republic of Korea

2Innsbruck Medical University, Innsbruck, Austria

3University Hospital Hamburg-Eppendorf, Hamburg, Germany

4University Hospital Leuven, Leuven, Belgium


Nephrotic Syndrome: Genetics, Mechanism, and Therapies

Description

Nephrotic syndrome is one of the most common glomerular diseases and renal histology reveals the presence of minimal change nephrotic syndrome (MCNS), focal segmental glomerulosclerosis (FSGS), and various kinds of glomerulonephritides also caused by systemic diseases. Recent advances in immunology, cell biology, and genetics have found new mechanisms in nephrotic syndrome. Understanding of the pathogenesis of nephrotic syndrome will lead to the better patient outcome.

We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts to understand the various aspects of nephrotic syndrome, including recent advances in podocyte biology, molecular genetics, pathology, immunology, animal models, treatment trials, and potential therapeutic strategies.

Potential topics include but are not limited to the following:

  • Advances in molecular genetics of podocytes in nephrotic syndrome
  • Advances in immunology in nephrotic syndrome
  • Relevance of various animal models of nephrotic syndrome
  • Renal histopathology in various kinds of nephrotic syndrome
  • Recent advances in treatments of nephrotic syndrome and randomized controlled trials
  • Recurrent original glomerulopathies after renal transplantation

Articles

  • Special Issue
  • - Volume 2018
  • - Article ID 6215946
  • - Editorial

Nephrotic Syndrome: Genetics, Mechanism, and Therapies

Jae Il Shin | Andreas Kronbichler | ... | Björn Meijers
  • Special Issue
  • - Volume 2017
  • - Article ID 1936372
  • - Review Article

Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy

Andreas Kronbichler | Jun Oh | ... | Jae Il Shin
  • Special Issue
  • - Volume 2017
  • - Article ID 6232616
  • - Review Article

Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor

Virginia J. Savin | Mukut Sharma | ... | Ellen T. McCarthy
  • Special Issue
  • - Volume 2017
  • - Article ID 7518789
  • - Review Article

NPHS2 Mutations: A Closer Look to Latin American Countries

Mara Sanches Guaragna | Anna Cristina G. B. Lutaif | ... | Maricilda P. De Mello
  • Special Issue
  • - Volume 2017
  • - Article ID 1757940
  • - Research Article

Pulsed Vincristine Therapy in Steroid-Resistant Nephrotic Syndrome

Shenal Thalgahagoda | Shamali Abeyagunawardena | ... | Asiri Samantha Abeyagunawardena
  • Special Issue
  • - Volume 2017
  • - Article ID 2180508
  • - Review Article

Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies

Michael Rudnicki
  • Special Issue
  • - Volume 2017
  • - Article ID 7689254
  • - Review Article

Recent Treatment Advances and New Trials in Adult Nephrotic Syndrome

Eva Königshausen | Lorenz Sellin
  • Special Issue
  • - Volume 2017
  • - Article ID 9531074
  • - Research Article

Cytoplasmic Localization of WT1 and Decrease of miRNA-16-1 in Nephrotic Syndrome

Pablo Zapata-Benavides | Mariela Arellano-Rodríguez | ... | Cristina Rodríguez-Padilla
BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
CiteScore3.600
Impact Factor2.276
 Submit